Skip to main content
. 2021 Dec 14;15(12):e0009844. doi: 10.1371/journal.pntd.0009844

Table 3. Mortality reported in included studies.

Study Location Study design Cases Mortality (%) Treatment
Tourdes, 1848 [177] Europe Case series 239 73% No drug therapy
Barthez, 1855 [177] Europe Case series 29 89% No drug therapy
Ritchie, 1872 [4] Europe Case series 8 63% Iron with citric-acid, nutritional support
Springer, 1904 [177] Europe Case series 88 94% Wound debridement
Gupta, 1945 [44] India Case series 79 49% Pentavalent antimony (treatment of leishmaniasis), nutritional support, vitamins, blood transfusions, local antiseptic treatment
Jelliffe, 1952 [37] Nigeria Case series 53 30% Penicillin
Mehrotra, 1966 [49] India Case series 20 15% Antibiotics, multivitamins, high protein diet, sequestrectomy, plastic reconstructive surgeries
Adekeye and Ord, 1978–1982 [13] Nigeria Case series 13 0% Antibiotics
Bourgeois, 1981–93 [13] Senegal Case series 73 10% Drug therapy, kind of treatment not specified
Oginni, 1982–96 [13] Nigeria Case series 133 0% Drug therapy, kind of treatment not specified
Nath, 1998 [15] Zambia Retrospective chart review 117 20% Nutrition, wound care
Chidzonga, 1996 [48] Zimbabwe Case series 8 38% Antibiotics, wound debridement, removed mobile teeth, irrigated wounds
Millogo, 2012 [122] Burkina Faso Retrospective chart review 212 HIV 38%; non- HIV patients 6% Antibiotics, anti-retroviral therapy
Konsem, 2014 [104] Burkina Faso Retrospective chart review 55 15% Antibiotics
Braimah, 2017 [147] Nigeria Retrospective chart review 159 25% Antibiotics